Cargando…
Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019
Background: Drug induced liver injury (DILI) is an adverse drug reaction that causes liver damage in a predictable (dose-dependent) or an unpredictable (idiosyncratic) fashion. We performed an assessment of DILI in Portugal, by analyzing the reports, sent to the Portuguese Pharmacovigilance System (...
Autores principales: | , , , |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
MDPI
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702164/ https://www.ncbi.nlm.nih.gov/pubmed/34946356 http://dx.doi.org/10.3390/healthcare9121630 |
_version_ | 1784621181117136896 |
---|---|
author | Nunes, David Ricardo da Conceição Marçal Alves Breton, Michèle Claire Monteiro, Cristina Sofia de Jesus dos Santos, Jorge Luiz |
author_facet | Nunes, David Ricardo da Conceição Marçal Alves Breton, Michèle Claire Monteiro, Cristina Sofia de Jesus dos Santos, Jorge Luiz |
author_sort | Nunes, David Ricardo da Conceição Marçal Alves |
collection | PubMed |
description | Background: Drug induced liver injury (DILI) is an adverse drug reaction that causes liver damage in a predictable (dose-dependent) or an unpredictable (idiosyncratic) fashion. We performed an assessment of DILI in Portugal, by analyzing the reports, sent to the Portuguese Pharmacovigilance System (PPS). Methods: A search was performed on the PPS database, in a 10-year time frame, from 1 January 2010 to 31 December 2019. Results: There was not a prevalence of either sex in any age group. Most reports (n = 1120, 55.0%) belonged to patients in the age group 19–64 years old. Hepatitis (n = 626, 26.7%) was the most common adverse drug reaction in our study. Hepatotoxicity (n = 362, 15.5%) and hepatitis (n = 333, 14.2%) were more frequent in age group 19–64 years old. Cholestasis was more prevalent in adults independently of age. Hepatic fibrosis and encephalopathy were more common in the elderly. Most patients consumed between one and four suspected drugs (n = 1867, 92%). Most patients in our study evolved to “cure” (n = 796; 39%). Hepatotoxicity (n = 23; 13.8%) and hepatitis (n = 610; 25.9%) had a female predominancy while choluria (n = 8; 4.8%) and splenomegaly (n = 8; 4.8%) were of male predominance. Conclusions: DILI is rare but can be fatal. As such, an active search of DILI is necessary. |
format | Online Article Text |
id | pubmed-8702164 |
institution | National Center for Biotechnology Information |
language | English |
publishDate | 2021 |
publisher | MDPI |
record_format | MEDLINE/PubMed |
spelling | pubmed-87021642021-12-24 Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019 Nunes, David Ricardo da Conceição Marçal Alves Breton, Michèle Claire Monteiro, Cristina Sofia de Jesus dos Santos, Jorge Luiz Healthcare (Basel) Article Background: Drug induced liver injury (DILI) is an adverse drug reaction that causes liver damage in a predictable (dose-dependent) or an unpredictable (idiosyncratic) fashion. We performed an assessment of DILI in Portugal, by analyzing the reports, sent to the Portuguese Pharmacovigilance System (PPS). Methods: A search was performed on the PPS database, in a 10-year time frame, from 1 January 2010 to 31 December 2019. Results: There was not a prevalence of either sex in any age group. Most reports (n = 1120, 55.0%) belonged to patients in the age group 19–64 years old. Hepatitis (n = 626, 26.7%) was the most common adverse drug reaction in our study. Hepatotoxicity (n = 362, 15.5%) and hepatitis (n = 333, 14.2%) were more frequent in age group 19–64 years old. Cholestasis was more prevalent in adults independently of age. Hepatic fibrosis and encephalopathy were more common in the elderly. Most patients consumed between one and four suspected drugs (n = 1867, 92%). Most patients in our study evolved to “cure” (n = 796; 39%). Hepatotoxicity (n = 23; 13.8%) and hepatitis (n = 610; 25.9%) had a female predominancy while choluria (n = 8; 4.8%) and splenomegaly (n = 8; 4.8%) were of male predominance. Conclusions: DILI is rare but can be fatal. As such, an active search of DILI is necessary. MDPI 2021-11-25 /pmc/articles/PMC8702164/ /pubmed/34946356 http://dx.doi.org/10.3390/healthcare9121630 Text en © 2021 by the authors. https://creativecommons.org/licenses/by/4.0/Licensee MDPI, Basel, Switzerland. This article is an open access article distributed under the terms and conditions of the Creative Commons Attribution (CC BY) license (https://creativecommons.org/licenses/by/4.0/). |
spellingShingle | Article Nunes, David Ricardo da Conceição Marçal Alves Breton, Michèle Claire Monteiro, Cristina Sofia de Jesus dos Santos, Jorge Luiz Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019 |
title | Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019 |
title_full | Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019 |
title_fullStr | Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019 |
title_full_unstemmed | Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019 |
title_short | Drug Induced Liver Injury: Perspective of the Adverse Drug Reaction Reports to the Portuguese Pharmacovigilance System from 2010 to 2019 |
title_sort | drug induced liver injury: perspective of the adverse drug reaction reports to the portuguese pharmacovigilance system from 2010 to 2019 |
topic | Article |
url | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8702164/ https://www.ncbi.nlm.nih.gov/pubmed/34946356 http://dx.doi.org/10.3390/healthcare9121630 |
work_keys_str_mv | AT nunesdavidricardodaconceicaomarcalalves druginducedliverinjuryperspectiveoftheadversedrugreactionreportstotheportuguesepharmacovigilancesystemfrom2010to2019 AT bretonmicheleclaire druginducedliverinjuryperspectiveoftheadversedrugreactionreportstotheportuguesepharmacovigilancesystemfrom2010to2019 AT monteirocristinasofiadejesus druginducedliverinjuryperspectiveoftheadversedrugreactionreportstotheportuguesepharmacovigilancesystemfrom2010to2019 AT dossantosjorgeluiz druginducedliverinjuryperspectiveoftheadversedrugreactionreportstotheportuguesepharmacovigilancesystemfrom2010to2019 |